# Immunogenicity and Safety Study of a Single Prime-Boost Vaccination Schedule With a H5N1 Influenza Vaccine in Adults

> **NCT00895544** · PHASE1,PHASE2 · COMPLETED · sponsor: **Alachua Government Services, Inc.** · enrollment: 231 (actual)

## Conditions studied

- Influenza
- Avian Influenza

## Interventions

- **BIOLOGICAL:** Influenza vaccine (whole virion, Vero cell derived)
- **BIOLOGICAL:** Influenza vaccine (whole virion, Vero cell derived)

## Key facts

- **NCT ID:** NCT00895544
- **Lead sponsor:** Alachua Government Services, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-05
- **Primary completion:** 2010-10
- **Final completion:** 2011-06
- **Target enrollment:** 231 (ACTUAL)
- **Last updated:** 2015-10-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00895544

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00895544, "Immunogenicity and Safety Study of a Single Prime-Boost Vaccination Schedule With a H5N1 Influenza Vaccine in Adults". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00895544. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*